Why Is Starling Oncology, Inc. (NASDAQ: STLN) Stock Down Today?

Starling Oncology, Inc. (NASDAQ: STLN) Summary

Starling Oncology, Inc. (NASDAQ: STLN) is trading up +3.04% at $6.45, reflecting a positive shift in investor sentiment today. The stock opened at $6.25 and has moved between $6.25 and $6.63 so far.

Trading volume is 1077628, which is 44% below its average, and the price action suggests buying interest.

Technically, STLN on the NASDAQ is trading above its 50-day moving average of $5.35 and above its 200-day moving average of $3.92, indicating short-term and long-term strength.

Analyst sentiment is bullish. Meyka's AI assigns STLN a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of +114.88% in 1 month ($13.86).

See full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement on the NASDAQ.
Stay informed and make better investment decisions.